Semaglutide provides cardio-protection in anthracycline-treated non-hodgkin lymphoma: a propensity-matched real-world study

28 August 2026 (14:22 - 14:41)
Organised by: Logo
Congress Presentation Part of: Real-world evidence in cardio-oncology: what is it and what can it tell us? Cardio-Oncology ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology